The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announces that at the…
Basal cell carcinoma and squamous cell carcinoma are the two most common types of skin cancers. According to the American Cancer Society, over 5 million cases of basal cell and squamous cell cancers are diagnosed…
Have your patients tried surgical methods of keloid removal, only to find that the keloid scar returns stronger than ever after the operation? Keloid scars are often very difficult to treat, because surgery can send…
BOCA RATON, Fla., Sept. 20, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that…
